Case report: Bevacizumab-induced cerebrovascular events: a case series report and literature review

Case report: Bevacizumab-induced cerebrovascular events: a case series report and literature review

In clinical use, bevacizumab has improved the overall survival (OS) and progression-free survival (PFS) of malignant solid tumors, and the safe use of bevacizumab has gradually become the mainstream direction of clinical, nursing and pharmaceutical research. Bevacizumab is a humanized anti-VEGF drug...

Full description

Saved in:
Bibliographic Details
Main Authors: Ke Chen, Boyang Jiang, Huiping Yan, Liu Yang, Zheling Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Oncology
Subjects:
bevacizumab
adverts effects
VEGF
cerebrovascular accident
cancer
case report
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1395129/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items